Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

prognostic factor

  • You have access
    The Systemic Inflammation Score Is an Independent Prognostic Factor for Esophageal Cancer Patients who Receive Curative Treatment
    TORU AOYAMA, MIHWA JU, KEISUKE KOMORI, HIROSHI TAMAGAWA, AYAKO TAMAGAWA, YUKIO MAEZAWA, ITARU HASHIMOTO, KAZUKI KANO, KENTARO HARA, HARUHIKO CHO, KENKI SEGAMI, DAISUKE MACHIDA, MASATO NAKAZONO, TAKASHI OSHIMA, NORIO YUKAWA and YASUSHI RINO
    Anticancer Research May 2022, 42 (5) 2711-2717; DOI: https://doi.org/10.21873/anticanres.15749
  • You have access
    Prognostic Impact of N2 of the Primary Tumour in Surgical Resection for Colorectal Liver Metastases
    KOICHI TOMITA, NAOKAZU CHIBA, SHIGETO OCHIAI, TAKAHIRO GUNJI, TOSHIMICHI KOBAYASHI, TORU SANO, EIJI HIDAKA and SHIGEYUKI KAWACHI
    Anticancer Research April 2022, 42 (4) 1997-2001; DOI: https://doi.org/10.21873/anticanres.15678
  • You have access
    Combination of DYRK2 and TERT Expression Is a Powerful Predictive Marker for Early-stage Breast Cancer Recurrence
    MASUMI TANAKA, SHIN-ICHI YAMASHITA, YASUTERU YOSHINAGA, YASUKO ENOMOTO, YUKI NOHARA, SYUKO ONO, KAZUKI NABESHIMA, AKINORI IWASAKI and TOSHIHIKO SATO
    Anticancer Research April 2022, 42 (4) 2079-2085; DOI: https://doi.org/10.21873/anticanres.15689
  • Open Access
    Programmed Cell Death Ligand-1 (PDL-1) Correlates With Tumor Infiltration by Immune Cells and Represents a Promising Target for Immunotherapy in Endometrial Cancer
    THOMAS HECKING, THORE THIESLER, JANINA HALBE, LUCIA OTTEN, FLORIAN RECKER, HEIDRUN GEVENSLEBEN, TIM MÜLLER, CYNTHIA SCHILLER, EVA K. EGGER, ROLF FIMMERS, MATTHIAS B. STOPE, GLEN KRISTIANSEN and ALEXANDER MUSTEA
    Anticancer Research March 2022, 42 (3) 1367-1376; DOI: https://doi.org/10.21873/anticanres.15606
  • You have access
    ypN0 in Patients With Definitive cN-positive Status After Preoperative Treatment Is a Prognostic Factor in Esophageal Cancer
    TAKAHIRO YOSHIDA, TAKESHI NISHINO, MASAKAZU GOTO, SEIYA INOUE, SATOSHI FUJIWARA, HIROMITSU TAKIZAWA, AKIRA TANGOKU, HISANORI UEHARA and YOSHIMI BANDO
    Anticancer Research January 2022, 42 (1) 195-203; DOI: https://doi.org/10.21873/anticanres.15473
  • You have access
    14-3-3 Sigma Protein Contributes to Hepatocyte Growth Factor-mediated Cell Proliferation and Invasion via Matrix Metalloproteinase-1 Regulation in Human Gastric Cancer
    JI YOON JUNG, SUNG AE KOH, KYUNG HEE LEE and JAE RYONG KIM
    Anticancer Research January 2022, 42 (1) 519-530; DOI: https://doi.org/10.21873/anticanres.15510
  • You have access
    BAF57 Is a Potential Determinant of Colorectal Cancer Malignancy
    HIROFUMI SUZUMURA, MASASHI TSURUTA, KOJI OKABAYASHI, KOHEI SHIGETA, RYO SEISHIMA, TAKASHI ISHIDA, TAKEHIRO SHIMADA, YUSUKE ASADA, KAORU KOISHIKAWA, SHINGO AKIMOTO, OSAMU ITANO, HIROTOSHI HASEGAWA and YUKO KITAGAWA
    Anticancer Research November 2021, 41 (11) 5445-5452; DOI: https://doi.org/10.21873/anticanres.15356
  • You have access
    Prognostic Value of Lower Tract Urinary Symptoms in Clinically Regional Lymph Node-positive Prostate Cancer
    LEANDRO BLAS, KOSUKE IEIRI, MASAKI SHIOTA, SHOHEI NAGAKAWA, SHIGEHIRO TSUKAHARA, TAKASHI MATSUMOTO, EIJI KASHIWAGI, ARIO TAKEUCHI, JUNICHI INOKUCHI, KEN-ICHIRO SHIGA, AKIRA YOKOMIZO and MASATOSHI ETO
    Anticancer Research November 2021, 41 (11) 5593-5598; DOI: https://doi.org/10.21873/anticanres.15373
  • You have access
    Prognostic Factors of Potential Early Recurrence of Hypopharyngeal Carcinoma
    DAISUKE BABA, CHIHIRO FUSHIMI, KENJI HANYU, TATSUO MASUBUCHI, YUICHIRO TADA and KOKI MURA
    Anticancer Research November 2021, 41 (11) 5761-5766; DOI: https://doi.org/10.21873/anticanres.15392
  • You have access
    Immunonutritional Indices in Non-small-cell Lung Cancer Patients Receiving Adjuvant Platinum-based Chemotherapy
    TAICHI MATSUBARA, FUMIHIKO HIRAI, MASAFUMI YAMAGUCHI and MOTOHARU HAMATAKE
    Anticancer Research October 2021, 41 (10) 5157-5163; DOI: https://doi.org/10.21873/anticanres.15333

Pages

  • Next
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
Anticancer Research

© 2022 Anticancer Research

Powered by HighWire